Roy Watts
Internal Medicine · Surprise, AZNPI 1770699308
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,048 and has fallen 92.5% since, to $79 in 2024.
Across 149 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342
- AstraZeneca$183
- Abbott$180
- Novartis$174
- Daiichi Sankyo Inc.$172
- Novo Nordisk$171
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $342 |
| AstraZeneca | 12 | $183 |
| Abbott | 10 | $180 |
| Novartis | 10 | $174 |
| Daiichi Sankyo Inc. | 9 | $172 |
| Novo Nordisk | 11 | $171 |
| Boehringer Ingelheim | 7 | $138 |
| GSK | 8 | $136 |
| Astellas Pharma US Inc | 5 | $112 |
| Pfizer | 7 | $101 |
| Sunovion Pharmaceuticals Inc. | 6 | $98 |
| Lilly USA, LLC | 7 | $97 |
| Nestle Healthcare Nutrition Inc. | 5 | $85 |
| Johnson & Johnson | 5 | $82 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Edwards Lifesciences | 3 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $72 |
| Boston Scientific | 3 | $52 |
| Nalu Medical, Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $33 |
| Amarin Pharma, Inc. | 2 | $29 |
| Mylan Specialty L.p. | 1 | $27 |
| Merck | 1 | $20 |
| Philips North America LLC | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $15 |
| Apria Healthcare LLC | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$2,593 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 34 | $1,016 |
| Atorvastatin Calcium | 18 | $275 |
| Levothyroxine Sodium | 16 | $242 |
| Lisinopril | 19 | $128 |
| Amlodipine Besylate | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Surprise
- Amardeep MajhailSurprise$12K
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
- Jacque SokolovScottsdale$235K
- Paul StanderPhoenix$222K
- Howard GrossmanPhoenix$131K
- Christine HarterGlendale$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.